Ezetimibe

Synopsis, Chemistry

APIs // Active Pharmaceutical Ingredients

75 Suppliers, 28 USDMF, 10 JDMF, 15 EU WC, 61 KDMF, 18 NDC API, 51 Listed Suppliers

DEVELOPMENTS

16 Drug(s) in Development

16 Drug(s) in Development

PRICE INFORMATION

API Reference Price, API Exports, API Imports, FDF Exports, FDF Imports

INTERMEDIATES

26 Suppliers

26 Suppliers

DOSSIERs // Finished Dosage Forms

330 Dossiers, 61 FDA Orange Book, 76 Europe, 20 Canada, 45 Australia, 30 South Africa, 98 Listed Dossiers

DRUG PRODUCT COMPOSITION

TABLET;ORAL - EQ 10MG BASE;10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - EQ 20MG BASE;10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - EQ 40MG BASE;10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - EQ 80MG BASE;10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 10MG, TABLET;ORAL - 10MG;10MG, TABLET;ORAL - 10MG;20MG, TABLET;ORAL - 10MG;40MG, TABLET;ORAL - 10MG;80MG

RELATED EXCIPIENT COMPANIES

Suppliers, 36 Kerry, 19 BASF, 18 Roquette, 13 Microlex e.U, 12 Sigachi Industries, 11 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 10 Gangwal Healthcare, 10 Corel Pharma Chem, 8 Gangwal Chemicals, 7 Seppic, 7 DFE Pharma, 6 Lonza Capsugel, 6 SPI Pharma, 5 Pharmatrans-Sanaq, 5 Prachin Chemical, 5 Boai NKY Pharmaceuticals Ltd, 5 Ideal Cures Pvt Ltd, 5 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 4 Ingredion Pharma Solutions, 4 Vasa Pharmachem, 3 Kima Chemical, 2 The Dow Chemical Company, 2 Alcedo Pharmachem, 2 Minakem, 2 Nanjing Well Pharmaceutical, 2 Jai Radhe Sales, 2 Ulanqab Kema New Material, 1 ACG Worldwide, 1 Qualicaps, 1 Aeon Procare, 1 Pharm-RX Chemical, 1 NEWEDGE Overseas, 1 DKSH, 1 Chynops Pharma, 1 Qianhao Chemical (Hebei) Co., Ltd

EXCIPIENTS BY APPLICATIONS

65 Fillers, Diluents & Binders, 45 Coating Systems & Additives, 44 Disintegrants & Superdisintegrants, 36 Direct Compression, 26 Granulation, 25 Controlled & Modified Release, 22 Lubricants & Glidants, 17 Thickeners and Stabilizers, 12 Co-Processed Excipients, 11 Chewable & Orodispersible Aids, 10 Solubilizers, 9 Taste Masking, 9 Film Formers & Plasticizers, 7 API Stability Enhancers, 5 Empty Capsules, 4 Parenteral, 4 Vegetarian Capsules, 3 Emulsifying Agents, 3 Rheology Modifiers, 2 Coloring Agents, 2 Topical

GLOBAL SALES INFORMATION

28 US Medicaid Prescriptions, 49 Finished Drug Prices

MARKET PLACE

16 APIs, 5 DOSSIERS // FDF

PATENTS

16 US Patents, 1 US Exclusivities, 2 Health Canada Patents

ANALYTICAL SOLUTION(s)

6 BioAnalytical Methods, 2 USP Standards, 2 Other Ref. Standards

DIGITAL CONTENT

8 Data Compilation & Company Tracker #PharmaFlow, 105 News

Information, Expiry & Status of Health Canada Patents covering Ezetimibe.

Ezetimibe

Synopsis

Chemistry

APIs // Active Pharmaceutical Ingredients

75 Suppliers

28 USDMF

10 JDMF

15 EU WC

61 KDMF

18 NDC API

51 Listed Suppliers

DEVELOPMENTS

16 Drug(s) in Development

PRICE INFORMATION

API Reference Price

API Exports

API Imports

FDF Exports

FDF Imports

INTERMEDIATES

26 Suppliers

DOSSIERs // Finished Dosage Forms

330 Dossiers

61 FDA Orange Book

76 Europe

20 Canada

45 Australia

30 South Africa

98 Listed Dossiers

DRUG PRODUCT COMPOSITION

TABLET;ORAL - EQ 10MG BASE;10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - EQ 20MG BASE;10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - EQ 40MG BASE;10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - EQ 80MG BASE;10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - 10MG

TABLET;ORAL - 10MG;10MG

TABLET;ORAL - 10MG;20MG

TABLET;ORAL - 10MG;40MG

TABLET;ORAL - 10MG;80MG

RELATED EXCIPIENT COMPANIES

Suppliers

36 Kerry

19 BASF

18 Roquette

13 Microlex e.U

12 Sigachi Industries

11 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

10 Gangwal Healthcare

10 Corel Pharma Chem

8 Gangwal Chemicals

7 Seppic

7 DFE Pharma

6 Lonza Capsugel

6 SPI Pharma

5 Pharmatrans-Sanaq

5 Prachin Chemical

5 Boai NKY Pharmaceuticals Ltd

5 Ideal Cures Pvt Ltd

5 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

4 Ingredion Pharma Solutions

4 Vasa Pharmachem

3 Kima Chemical

2 The Dow Chemical Company

2 Alcedo Pharmachem

2 Minakem

2 Nanjing Well Pharmaceutical

2 Jai Radhe Sales

2 Ulanqab Kema New Material

1 ACG Worldwide

1 Qualicaps

1 Aeon Procare

1 Pharm-RX Chemical

1 NEWEDGE Overseas

1 DKSH

1 Chynops Pharma

1 Qianhao Chemical (Hebei) Co., Ltd

EXCIPIENTS BY APPLICATIONS

65 Fillers, Diluents & Binders

45 Coating Systems & Additives

TABLET;ORAL - EQ 10MG BASE;10MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL - EQ 20MG BASE;10MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL - EQ 40MG BASE;10MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL - EQ 80MG BASE;10MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons